Related by context. All words. (Click for frequent words.) 72 mAbs 68 monoclonal antibodies 67 therapeutic monoclonal antibodies 67 MAb 67 cancer immunotherapies 66 IMA# 65 dAbs 65 monoclonal antibody mAb 65 GAP #B# 65 AEG# 65 humanized monoclonal antibodies 65 nanoviricides 65 molecularly targeted 65 mAb 64 ENMD # 64 proteasome inhibitor 64 MEK inhibitors 64 tubulin inhibitor 64 Litx 64 Sym# 64 Anticalins ® 64 kinase inhibitors 64 monoclonal antibodies mAbs 64 Onconase 64 immunotherapeutic 64 polyclonal antibodies 63 cytotoxics 63 therapeutic monoclonal antibody 63 anti CD# antibodies 63 humanized antibody 63 PI3K inhibitors 63 Monoclonal antibodies 63 monoclonal antibodies MAbs 63 transfection reagents 63 recombinant antibodies 63 anti CD3 63 CCX# 63 OncoVEX 63 antisense drugs 63 triphendiol 63 GRNVAC1 63 shRNA libraries 63 PEGylated 63 therapeutic antibody 62 therapeutics 62 splice variants 62 DXL# 62 BiTE 62 proteasome inhibitors 62 Telatinib 62 humanized antibodies 62 phage display 62 fusion proteins 62 CD# antibody [001] 62 prophylactic vaccines 62 Panzem 62 eTag assays 62 RhuDex ® 62 bispecific antibody 62 Monoclonal Antibody 62 FLT3 62 polyclonal antibody 62 monoclonal antibody therapeutics 62 Exelixis compounds 62 OMP #M# 62 mertansine 62 Gleevec resistant 62 monoclonal 62 AP# [003] 62 renin inhibitors 62 rxRNA 62 ProLindac 62 chimeric antibodies 62 histone deacetylase inhibitor 62 DOS# 61 EpCAM 61 vascular disrupting agents 61 cancer immunotherapy 61 NEUGENE 61 Anticalins 61 SERMs 61 Monoclonal Antibodies 61 radionuclide therapy 61 novel peptide 61 selective kinase inhibitor 61 Archexin 61 pan HDAC inhibitor 61 small molecule inhibitors 61 recombinants 61 EndoTAG TM -1 61 multitargeted 61 PSMA ADC 61 vascular disrupting agent 61 antisense oligonucleotides 61 inhibit EGFR 61 Solazed TM 61 adenoviral 61 antibody 61 OvaRex R 61 cleavable linker 61 Nanobodies 61 YONDELIS R 61 orally bioavailable 61 Interferon alpha 61 Onalta ™ 61 druggable targets 61 predictive biomarkers 61 Clofarabine 61 humanised antibody 61 humanized anti 61 BCR ABL inhibitors 61 transfection reagent 61 CD# antibodies 61 biologic therapeutics 61 M2 subunit 61 Anticalins R 61 protein kinase inhibitor 61 polymerase inhibitors 61 antiviral compounds 61 Azedra 61 HERmark 61 preclinically 61 glycosylated 60 IgG antibodies 60 JAK2 inhibitors 60 OHR/AVR# 60 TG# [001] 60 CHO cells 60 HyperAcute 60 trastuzumab DM1 60 JAK3 60 receptor tyrosine kinase inhibitor 60 depsipeptide 60 immunotherapeutics 60 monoclonal antibody 60 DNA methylation biomarkers 60 UsiRNAs 60 rxRNA compounds 60 ocular formulation 60 affinity antibodies 60 Allovectin 7 R 60 YONDELIS 60 antiviral therapies 60 Aurora kinase 60 hybridomas 60 ganetespib 60 GPCR targets 60 HSP# inhibitor 60 lentiviral vectors 60 oncoproteins 60 diagnostic biomarkers 60 Kinase inhibitors 60 Taxanes 60 isoform selective 60 peptide antigens 60 immunotoxin 60 siRNA sequences 60 oncolytic virus 60 JAK1 60 ESBA# 60 molecular assays 60 Onalta TM 60 Pertuzumab 60 NPC 1C 60 Nanobody 60 Smac mimetic 60 radiation sensitizer 60 antisense inhibitors 60 Velcade bortezomib 60 FGFR 60 Trofex 60 siRNAs targeting 60 XmAb# 60 Ceflatonin 60 anticancer therapies 60 HuLuc# 60 tolevamer 60 hybridoma 60 XmAb 60 vitro assay 60 Tyrima 60 investigational humanized monoclonal antibody 60 Tumour Vascular Disrupting Agent 60 diagnostic assays 60 Anticalin 60 Panzem R NCD 60 ETBs 59 therapeutic antibodies 59 OncoVEX GM CSF 59 epithelial tumors 59 miRNA biomarkers 59 NADiA ProsVue 59 ATL# [001] 59 huC# DM4 59 HER2 receptor 59 integrin receptors 59 novel anticancer 59 HGS ETR1 59 VitiGam 59 BRAF inhibitor 59 RNAi therapeutic 59 Xanafide 59 EndoTAG 59 entinostat 59 CEQ# 59 cytotoxic agents 59 IMC #B 59 immunotherapies 59 OncoVex 59 XL# XL# 59 Aplidin 59 shRNAs 59 Nanobodies ® 59 T#I [002] 59 HCV protease inhibitors 59 PARP inhibitors 59 tumor antigens 59 camptothecin 59 A3 adenosine receptor 59 immunoconjugate 59 antiproliferative effects 59 MEK inhibitor 59 TLR9 agonists 59 AMPK activators 59 anticancer compounds 59 Anticalin ® 59 molecular biomarkers 59 Zolinza 59 ALN VSP 59 chimeric monoclonal antibody 59 synthetic peptides 59 indibulin 59 tyrosine kinase inhibitor 59 Immunotherapeutic 59 delta isoform 59 delafloxacin 59 trabectedin 59 JAK#/JAK# 59 DNA plasmids 59 CXCR4 receptor 59 miRNA therapeutics 59 BRAF inhibitors 59 enveloped viruses 59 targeted radiotherapeutic 59 Trofex TM 59 peptidomimetic 59 multiplexed assays 59 interferon IFN 59 RAV# 59 Japanese Encephalitis vaccine 59 Multiferon R 59 anticancer agent 59 Vidofludimus 59 deacetylase inhibitors 59 polyclonal 59 PER.C6 ® 59 Symadex 59 ddRNAi 59 rhIL 7 59 anticancer therapeutics 59 myeloma cells 59 pertuzumab 59 Locked Nucleic Acid LNA 59 PCA3 test 59 EGFR inhibitors 59 humanized monoclonal antibody 59 multiplex assay 59 NSCLC tumors 59 HCV protease 59 nanomedicines 59 siRNA therapeutics 59 tumor antigen 59 non nucleoside 59 personalized immunotherapy 59 Fc fusion protein 59 VDAs 59 bardoxolone 59 protein kinase inhibitors 59 cMET 59 oncolytic 59 #D#C# 59 PORxin 59 XmAb ® 59 recombinant proteins 59 hematological cancers 59 iPSC 59 ZK EPO 59 deforolimus 59 oral taxane 59 Insegia 59 antimitotic 59 GLP toxicology studies 59 MyVax R 59 HyACT 59 potent inhibitors 59 miRview mets 59 CDK inhibitors 59 S/GSK# 59 PI3K/mTOR 59 nucleotide analogs 59 BAY #-# 59 JAK inhibitors 59 miR #a [002] 59 FluCide 59 Affibody ® molecules 58 epothilone 58 CCR9 antagonist 58 Vorinostat 58 drug conjugate 58 antibody fragment 58 radiotherapeutic 58 miRview ™ squamous 58 siRNA therapeutic 58 Urocidin 58 CD# CEA 58 prostone 58 c MET 58 human hepatocytes 58 IGF 1R 58 Thrombin 58 diagnostic biomarker 58 PER.C6 ® cell 58 imatinib Gleevec 58 anionic backbone 58 nanomolar 58 Milatuzumab 58 inhibiting tumor 58 PORxin TM 58 Squalamine 58 5 hmC 58 trastuzumab Herceptin 58 Antibody 58 antisense inhibitor 58 HuMax CD4 58 antibodies 58 myeloproliferative disorders 58 PI3K inhibitor 58 oxidative stress inducer 58 Curaxin 58 CYC# 58 PXD# 58 chemotherapeutic drug 58 Tarvacin TM 58 Neuradiab 58 TLR agonists 58 AMN# [001] 58 somatostatin analogue 58 Micromet BiTE 58 Factor VIIa 58 IMGN# 58 CCR5 inhibitors 58 MVA BN R 58 mTOR inhibitors 58 antagomirs 58 FK# 58 Factor Receptor 58 splice variant 58 antiangiogenic agents 58 Aptamer 58 chemically modified siRNA 58 tumor xenograft models 58 myelofibrosis polycythemia vera 58 tyrosine kinase inhibitors 58 Stapled Peptide 58 prognostic markers 58 LNP formulations 58 POTELLIGENT ® 58 Scancell 58 Genentech Rituxan 58 trastuzumab DM1 T DM1 58 SuperAntibody 58 HDACi 58 Cervista HPV HR 58 immune modulating 58 JVRS 58 antibody MAb 58 telomerase inhibitor 58 ZEVALIN ® 58 EGFR HER2 58 OMAPRO 58 Epigenomics proprietary 58 TG# [003] 58 CBLC# 58 cytotoxin 58 RECOTHROM R 58 Erlotinib 58 plasmid DNA vaccine 58 Sphingomab 58 NS#/#A protease 58 Alocrest 58 Romidepsin 58 anti CD# antibody 58 tyrosine kinase receptor 58 Pralatrexate 58 AtherOx 58 MKC# MT 58 radezolid 58 selective immunoproteasome inhibitor 58 IMC A# 58 histone deacetylase HDAC inhibitor 58 Campath ® 58 HER1 58 carbohydrate polymer 58 targeting CD# 58 Amrubicin 58 IL# PE#QQR 58 epigenetic therapies 58 metaglidasen 58 erlotinib Tarceva ® 58 TKIs 58 vinca alkaloid 58 anticancer agents 58 Virulizin ® 58 epigenetic therapeutics 58 Tarvacin 58 benzimidazole 58 oral prodrug 58 EGFRvIII 58 immunotoxins 58 MT#/MEDI-# 58 OXIGON TM 58 xenograft models 58 NXL# 58 MUC1 58 CD# expressing 58 anti CD3 monoclonal 58 biotherapeutics 58 Azedra TM 58 PDE4 inhibitor 58 ALK inhibitors 58 zanolimumab 58 alvespimycin 58 Myocet 58 histone deacetylase HDAC 58 seliciclib 58 enzastaurin 58 oral antiviral 58 pralatrexate 58 Granulocyte Colony Stimulating Factor 58 antisense drug 58 RNAi therapeutic targeting 58 ARIKACE ™ 58 imatinib Gleevec ® 58 Blinatumomab 58 lentiviral vector 58 antibody MT# 58 Carfilzomib 58 glycosylation profile 57 VLPs 57 ErbB3 HER3 57 Hsp# inhibition 57 Nanobody ® 57 monoclonals 57 Personalized Immunotherapy 57 Quinamed 57 ISF# 57 LEX System 57 AVI NEUGENE 57 Mammostrat 57 IMPDH 57 INT# [002] 57 biomarkers 57 cytotoxicity assays 57 CytoFabTM 57 miRview TM mets 57 Camptothecin 57 TNFa 57 therapeutically relevant 57 cells hESCs 57 Anticalin R 57 AVE# 57 ASONEP 57 ALN TTR 57 HTS assay 57 Zysolin TM 57 Ramoplanin 57 SIR Spheres 57 investigational compounds 57 tramiprosate 57 Fludara ® 57 Proxinium TM 57 ErbB3 57 stem cell therapeutics 57 EGFR HER 57 IgG1 antibody 57 biomarker 57 P#X# 57 recombinant vaccines 57 Tumor Necrosis Factor 57 JAK inhibitor 57 T DM1 57 Trastuzumab 57 eIF 4E 57 SNALP 57 oral proteasome inhibitor 57 MDV# 57 ALK inhibitor 57 Elagolix 57 Radezolid 57 vorinostat 57 EOquin 57 Biomerk Tumorgrafts 57 recombinant antibody 57 anti EGFR antibody 57 siRNA compounds 57 antiangiogenesis therapies 57 Monoclonal antibody 57 antibody therapeutics 57 GMX# 57 Septin9 57 Nucleic acids 57 Azedra ™ 57 VEGF receptor 57 novel orally bioavailable 57 Evoltra ® 57 drug GAP #B# 57 Epidermal Growth Factor Receptor 57 HER2 antibody 57 PET tracers 57 Anavex #-# 57 CYT# potent vascular disrupting 57 anti CD# monoclonal 57 soluble receptor 57 targeted antifolate 57 hormone gastrin 57 immunological diseases 57 flavopiridol 57 Civacir 57 hpSCs 57 Bioral ® 57 microRNA miR 57 Hemopurifier 57 Hemopurifier TM 57 Gefitinib 57 cytostatic 57 bispecific antibodies 57 K ras mutations 57 Antisense 57 KSP inhibitor 57 PEG SN# 57 Kevetrin ™ 57 biobetter 57 K RAS 57 monoclonal anti 57 mitotic kinesins 57 Epi proColon 57 immune stimulatory 57 JAK2 inhibitor 57 HAAH 57 CRD5 57 Gleevec imatinib mesylate 57 DAVANAT 57 NPM1 57 tumorigenic 57 anticancer drugs 57 Onalta 57 methylated DNA 57 HDAC inhibitors 57 Azacitidine 57 BrachySil TM 57 Hepatocytes 57 tiapamil 57 accumulate preferentially 57 Neuvenge 57 mapatumumab 57 antiangiogenesis 57 MCSP respectively 57 Curaxins 57 chemotherapeutic agents 57 KinomeScan 57 AGS PSCA 57 IGF IR 57 human monoclonal antibody 57 PNT# 57 cisplatin resistant 57 PARP inhibitor 57 Activity Assay 57 DCVax R 57 alpha interferon 57 nanoviricide drug 57 epothilones 57 Multiferon ® 57 Phase Ib study 57 SNALP technology 57 Ozarelix 57 ASA# 57 NEUGENE antisense 57 pDCs 57 nanoviricide 57 p# inhibitors 57 cellular immunotherapy 57 HDAC 57 ELISA kit 57 ELISPOT assay 57 nucleoside analogues 57 Solazed ™ 57 LentiVector technology 57 SIRT1 activators 57 biomarker identification 57 HPAPIs 57 kinase profiling 57 intravesical instillation 57 ALS #-# 57 IMP# 57 selective inhibition 57 MAPK pathway 57 EGFr 57 MGCD# [001] 57 VEGF receptor inhibitor 57 omacetaxine 57 tanespimycin 57 L BLP# 57 FGFR3 57 androgen receptor antagonist 57 molecular profiling 57 TLR8 57 BiTE antibody 57 fusion inhibitor 57 Cytotoxic 57 Hemopurifier ® 57 investigational therapies 57 rhIGFBP 3 57 tyrosine kinase inhibitors TKIs 57 PLX# 57 telomerase therapeutic 57 HCV protease inhibitor 57 synthetic siRNA 57 favorable pharmacokinetic profile 57 biomarker assay 57 Dasatinib 57 BAL# [001] 57 TREANDA 57 CCR5 antagonist 57 farletuzumab 57 immatics 57 Eg5 57 HuCAL antibody 57 ADME Tox 57 aptamers 57 Solazed 57 iCell Cardiomyocytes 57 antibody conjugates 57 siRNA transfection 57 oral gallium 57 recombinant albumin 57 Lacromin 57 Annexin V 57 Aurora kinase inhibitor 56 LB# [003] 56 SAR# [002] 56 dasatinib Sprycel 56 TRV# [001] 56 immunogens 56 polyketides 56 SAR# [004] 56 RayBiotech 56 ImmunoGen TAP technology 56 mitogen activated ERK kinase 56 PEP# [003] 56 miltefosine 56 Davanat 56 anti infective treatments 56 Src inhibitors 56 Fibroblast Growth Factor Receptor 56 Cloretazine 56 monoclonal antibody MAb 56 butyrylcholinesterase 56 Nexavar ® 56 small molecule agonists 56 PDGF receptor 56 nCounter Analysis System 56 elacytarabine 56 Mitoxantrone 56 stable nucleic acid 56 Cintredekin Besudotox 56 EndoTAG TM 56 MenSCs 56 Th2 cytokines 56 MOZOBIL 56 molecular entities NMEs 56 theranostics 56 thymidylate synthase TS 56 virotherapy 56 androgen receptor AR 56 Recombinant Human 56 FOLOTYN ® 56 Exelixis XL# 56 Epothilones 56 rituximab Rituxan 56 AQ4N 56 talabostat 56 MAGE A3 56 SIMPLE Antibody TM 56 AAV vectors 56 murine antibodies 56 Guanilib 56 EGFR antibodies 56 FUS1 56 Zemiva TM 56 Bezielle 56 HuMax CD# 56 CR# vcMMAE 56 ASG 5ME 56 potently inhibit 56 prodrugs 56 GV# [001] 56 VeraTag 56 pharmacological chaperone 56 Angiolix 56 Fleximer 56 VentiRx 56 molecular diagnostic 56 MAbs targeting 56 Bortezomib 56 Vicinium TM 56 VSV G 56 anticancer compound 56 monomeric 56 Allovectin 7 r 56 GW# [003] 56 orphan GPCRs 56 recombinant insulin 56 Ridaforolimus 56 BRAF mutation 56 antisense oligonucleotide 56 calcineurin inhibitors 56 Allovectin 7 56 TRAIL receptor antibodies 56 proprietary LNA 56 orally dosed 56 liposomal doxorubicin 56 kidney urologic 56 defensin mimetic antibiotic 56 vidofludimus 56 E#F# 56 LungExpress Dx 56 GRN#L 56 cytotoxic 56 Hsp# inhibitor 56 Novavax VLP vaccine 56 protein biomarkers 56 GRN# 56 sodium glucose transporter 56 Epitomics 56 VEGF Trap 56 Dicer Substrate Technology 56 preclinical compounds 56 UltiMAb 56 qRT PCR 56 mouse xenograft models 56 selective orally bioavailable 56 microtubule inhibitor 56 PathFinderTG 56 ALN PCS 56 Radilex 56 protein therapeutics 56 isotypes 56 TÎ ² 4 56 Ganciclovir 56 Monoclonal 56 Scil Proteins 56 Tofacitinib 56 EpiCeram 56 NADiA 56 ZP# [002] 56 hepatoma 56 synthetic retinoid 56 gastrointestinal stromal tumors GISTs 56 HGS ETR2 56 imatinib mesylate 56 phenotyping 56 FlexmiR 56 FVIIa 56 bevacizumab Avastin ® 56 neuropilin 56 seliciclib CYC# 56 Octreotide 56 RNA antagonist 56 nonviral 56 nucleoside analogs 56 protein mTOR 56 Novolimus 56 glioblastoma cells 56 Microspheres 56 vivo validation 56 Treanda 56 cyclin dependent kinase inhibitor 56 preanalytical solutions 56 vinca alkaloids 56 kinase inhibition 56 TKM ApoB 56 EZN 56 veltuzumab 56 small molecule tyrosine 56 IAP inhibitors 56 Hepatocellular Carcinoma HCC 56 Antigenics QS 56 nucleoside analog 56 Tarvacin Anti Viral 56 vaccine GRNVAC1 56 MicroRNA 56 RenaZorb 56 xenografts 56 Aflibercept 56 Marqibo TM 56 Herceptin trastuzumab 56 adenoviral vectors 56 EGF receptor 56 EV# vaccine 56 Fodosine 56 isavuconazole 56 rolapitant 56 Aviptadil 56 brostallicin 56 cathepsins 56 monoclonal antibody therapies 56 THR beta agonist 56 Ceflatonin R 56 retroviral vectors 56 LY# [003] 56 Removab 56 echinocandins 56 annexin V 56 colon carcinoma 56 ribonuclease 56 protein biomarker 56 oral JAK1 56 transfected cells 56 Urocidin TM 56 antibody arrays 56 systemic RNAi 56 preclinical efficacy 56 CD# monoclonal antibody 56 midstage studies 56 Olaparib 56 microtissues 56 Novartis Gleevec 56 Sertoli cell 56 Sapacitabine 56 rNAPc2 56 Rigel R# 56 Relivar 56 hA# 56 DNA methylation biomarker 56 compound AEZS 56 Oligonucleotide 56 miRview ™ mets 56 therapeutic mAbs 56 PGL# 56 thymalfasin 56 RT qPCR 56 tkRNAi technology 56 Loramyc R 56 LHRH 56 CDDO Im 56 ANYARA 56 PKC# 56 R#/MEM # 56 obatoclax 56 LHRH antagonists 56 Cloretazine R VNP#M 56 ARRY # 56 Kinase Inhibitor 56 chemical entities NCEs 56 cancer therapeutics 56 WT1 56 forodesine 56 antitumoral 56 Interferon alpha 2b 56 proteomic biomarkers 56 Estrogen Receptor 56 Neulasta ® 56 poly ADP ribose polymerase 56 Dalbavancin 56 Pazopanib 56 BrachySil 56 novel peptides 56 Trofile assay 56 Phase #b/#a clinical 56 Traficet EN 56 Docetaxel 56 anti angiogenic drugs 56 Neulasta R 56 lymphoid cells 56 Preclinical studies suggest 56 Phase IIb clinical trials 56 mda 7 56 bactericidal activity 56 pexiganan 56 GenPath 56 G Protein Coupled 56 EAA TM 56 Sutent sunitinib 56 Novasome R 56 hormone refractory 56 hypermethylated 56 biologic therapies 56 NNRTIs 56 CompoZr 56 APTIMA HPV assay 56 PTP 1B 56 Panzem NCD 56 registrational trial 56 Poly ICR 56 shRNA 56 HDACs 56 CCR5 antagonists 56 Campath alemtuzumab 56 Decitabine 56 prophylactic vaccine 56 Axiogenesis 56 lipopeptide 56 Homspera TM 56 highly immunogenic 56 echinocandin 56 immunomodulator 56 nucleoside 56 VEGF inhibitors 56 LC MALDI 56 glioma cells 56 druggable 56 HuCNS SC ® 56 ELND-#/AZD-# 56 Apaziquone 56 PEGylated interferon 56 Phylomer ® 56 nanocarriers 56 LEUKINE 56 Reverset 56 infected macrophages 56 immunomodulating 56 tivozanib 56 effector function 55 secreted proteins 55 ketolide antibiotic 55 B CLL 55 Alferon LDO 55 TTR gene 55 mature dendritic cells 55 5 HT2C receptor 55 Theranostics 55 inhibit viral replication 55 picomolar 55 MGd 55 p# inhibitor 55 kinase inhibitor 55 xCELLigence System 55 including eniluracil ADH 55 TLR8 agonist 55 Interferon alfa 55 OnDose TM 55 PRT# 55 antiviral therapeutics 55 retapamulin 55 IGFBP7 55 Phylomer 55 Phage Pharmaceuticals 55 Alemtuzumab 55 DermaVir 55 lentiviral 55 NP2 55 pegylated interferons 55 nicotinic acetylcholine receptor 55 tkRNAi 55 TELCYTA TM TLK# 55 induce apoptosis 55 CTLs 55 menstrual stem cell 55 gamma secretase inhibitors 55 ATL# [002] 55 Intravenous CP 55 NITD# 55 Zybrestat 55 chemotherapeutics 55 RGB # 55 OXi# 55 oligonucleotide therapeutics 55 ANG# 55 potent antiproliferative 55 TNF alpha inhibitors 55 geldanamycin 55 Nexavar sorafenib 55 oncolytic viruses 55 enzyme inhibitor 55 Chimigen TM 55 Cephalosporins 55 ACTCellerate 55 SARMs 55 radiolabeled TM# 55 Mesenchymal Stem Cells 55 cannabinor 55 T#I mutant 55 Omacetaxine 55 Soliris eculizumab 55 Vidaza azacitidine 55 mesothelin 55 humanized monoclonal 55 cytotoxic therapies 55 direct thrombin inhibitors